Hereditary Angioedema Market is estimated to be US$ 6.36 billion by 2030 with a CAGR of 8.9% during the forecast period
The Hereditary Angioedema (HAE) market continues to witness significant growth and innovation, driven by advancements in research and treatment options. […]